We are live on ! Find out more
TVRD

Tvardi Therapeutics
TVRD

42 hedge funds and large institutions have $160M invested in Tvardi Therapeutics in 2014 Q1 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
+42
Holders Change %
–
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
42
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCP
Rho Capital Partners
New York
+$43.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.6M
3
LBG
Lloyds Banking Group
United Kingdom
+$14.6M
4
Franklin Resources
Franklin Resources
California
+$10.7M
5
JP Morgan Chase
JP Morgan Chase
New York
+$5.99M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
26
Nationwide Fund Advisors
Ohio
$411K +$363K +613 New
Northern Trust
27
Northern Trust
Illinois
$377K +$332K +562 New
BIM
28
BlackRock Investment Management
Delaware
$275K +$243K +411 New
BWP
29
Baldwin Wealth Partners
Massachusetts
$251K +$222K +375 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$245K +$216K +365 New
EEG
31
E.E. Geduld
$242K +$214K +361 New
Jane Street
32
Jane Street
New York
$230K +$203K +343 New
TA
33
Teachers Advisors
New York
$215K +$189K +320 New
SCA
34
SAC Capital Advisors
Connecticut
$208K +$183K +310 New
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$182K +$161K +272 New
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$182K +$164K +278 New
Wells Fargo
37
Wells Fargo
California
$97K +$85.2K +144 New
TRCT
38
Tower Research Capital (TRC)
New York
$68K +$60.3K +102 New
BA
39
BlackRock Advisors
Delaware
$46K +$40.2K +68 New
AIG
40
American International Group
New York
$40.9K +$36.1K +61 New
Deutsche Bank
41
Deutsche Bank
Germany
$24K +$21.9K +37 New
Barclays
42
Barclays
United Kingdom
$3K +$2.37K +4 New
1
2

TVRD Hedge Fund Activity: Q1 2014 in Review

42 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Tvardi Therapeutics (TVRD) for Q1 2014, worth a combined $160M.

Buyers outnumbered sellers: 42 funds opened new TVRD positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Rho Capital Partners, opening a new position worth an estimated $43.8M.

  • 42 institutional investors held Tvardi Therapeutics (TVRD) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $160M of Tvardi Therapeutics stock for Q1 2014.
  • 42 funds opened new Tvardi Therapeutics positions in Q1 2014 and 0 closed out, a net change of +42 holders.
  • The largest Tvardi Therapeutics buyer in Q1 2014 was Rho Capital Partners, an estimated $43.8M added.

Based on aggregated 13F filings for Q1 2014.